Your browser doesn't support javascript.
How Did We Get a COVID-19 Vaccine in Less Than 1 Year?
Wherry, E John; Jaffee, Elizabeth M; Warren, Nicholas; D'Souza, Gypsyamber; Ribas, Antoni.
  • Wherry EJ; Department of Systems Pharmacology and Translational Therapeutics, Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. aribas@mednet.ucla.edu wherry@pennmedicine.upenn.edu.
  • Jaffee EM; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
  • Warren N; American Association for Cancer Research, Philadelphia, Pennsylvania.
  • D'Souza G; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Clin Cancer Res ; 27(8): 2136-2138, 2021 04 15.
Article in English | MEDLINE | ID: covidwho-1112357
ABSTRACT
The successful development of COVID-19 vaccines within an unprecedented short time needs to be followed by rapid vaccine uptake, in particular, in high-risk populations such as patients with cancer. It is important for the scientific research community and cancer physicians to convey the knowledge behind the COVID-19 vaccine development and contribute to build the required trust on their use.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Clin Cancer Res Journal subject: Neoplasms Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Clin Cancer Res Journal subject: Neoplasms Year: 2021 Document Type: Article